Medical News

RSS

Primary and original booster mRNA vaccination can reduce the risk of Omicron-related infection

mRNA COVID-19 vaccines are less effective against Omicron infections than other variants. A study publishing December 1st in the open access journal PLOS Medicine by Margaret L. Lind at the Yale School of Public Health, U.S. and colleagues suggests that the additional protection offered by the initial booster shot may be reduced among people with a previous COVID-19 infection.

1 Dec 2022

New program lowers the risk of car crashes for teenagers with ADHD

Research published in the New England Journal of Medicine has shown that a computerized program enhanced with driving simulation training with feedback lowers the risk of car crashes for teenagers with Attention Deficit Hyperactivity Disorder (ADHD).

1 Dec 2022

Best practices and challenges in One Health approach to fight zoonotic diseases

Announcing a new article publication for Zoonoses journal. Zoonoses are infectious diseases that can be transmitted from animals to humans and/or from humans to animals.

1 Dec 2022

Self-driven healthcare ecosystems could help improve health outcomes and control costs

A vision for building sustainable, self-driven healthcare spanning primary care, secondary care and the wider health and social care system has been set out by medical innovators writing in the Journal of the Royal Society of Medicine.

1 Dec 2022

LSHTM researchers launch new global health research group on HIV-associated fungal infections

Researchers from the London School of Hygiene & Tropical Medicine are co-launching a new global health research group on HIV-associated fungal infections.

1 Dec 2022

Study implicates gut microbiome health in Parkinson's disease

A new study published in the journal Nature Communications discusses the links between this condition that affects the brain and changes in the gut microbiome that may predate brain changes.

1 Dec 2022

First-in-humans test provides promising results for a broadly neutralizing antibody HIV vaccine

A Phase 1 clinical trial provides promising results for a broadly neutralizing antibody (bnAb) HIV vaccine, according to a new study.

1 Dec 2022

Gargling with povidone-iodine may reduce salivary viral load in COVID-19 patients

A prospective, randomized, open-level clinical trial demonstrates that gargling with povidone-iodine accelerates viral clearance and reduces saliva infectivity in patients with asymptomatic or mild coronavirus disease 2019 (COVID-19). The trial findings have been published in the journal Scientific Reports.

1 Dec 2022

Researchers develop a self-powered ingestible sensor system to monitor intestinal metabolites

Engineering researchers have developed a battery-free, pill-shaped ingestible biosensing system designed to provide continuous monitoring in the intestinal environment.

1 Dec 2022

Very low-calorie and vegan diets improve glycemic control in type 2 diabetes

Very low-calorie diets and vegan diets improve weight loss and anthropometric markers in type 2 diabetes patients.

1 Dec 2022

Human T cell immunity is coping with mutations in SARS-CoV-2 variants of concern

Immune T cells are continuing to target the spike protein of SARS-CoV-2 variants of concern, although mutations are making some T cells less effective, according to new research.

1 Dec 2022

Prior infection and vaccination protects against severe outcomes from SARS-CoV-2 Omicron infection

Previous infection with SARS-CoV-2 and booster vaccination protect against ICU admission and mortality following infection with the Omicron variant.

1 Dec 2022

Using DECT-derived metrics to definitively diagnose incidental adrenal adenomas

According to an open-access Editor's Choice accepted manuscript published in ARRS' American Journal of Roentgenology, for adrenal lesions evaluated by single-phase dual-energy CT (DECT), fat fraction had higher sensitivity than virtual non-contrast attenuation at both the clinically optimal threshold and at the traditional ≤10 HU threshold.

1 Dec 2022

COVID-19 infection may lead to long-term liver injury

COVID-19 infection is associated with increased liver stiffness, a sign of possible long-term liver injury, according to the results of a new study being presented today at the annual meeting of the Radiological Society of North America.

1 Dec 2022

Two experimental mRNA vaccines highly effective in reducing malaria infection and transmission

Malaria is found in more than 90 countries around the world, causing 241 million cases and an estimated 627,000 deaths every year.

1 Dec 2022

Harmful gut bacteria co-opt a genetic susceptibility to trigger Crohn’s disease

Changes in a single gene open the door for harmful gut bacteria to set off the inflammation that drives Crohn’s disease, according to a new study led by Weill Cornell Medicine and NewYork-Presbyterian investigators.

1 Dec 2022

Study identifies optimal blood tests for Alzheimer's detection and disease monitoring

A new study have identified which blood tests are best at detecting Alzheimer's disease during the earliest stages, and another blood test that is optimal for detecting relevant treatment effects.

1 Dec 2022

Research shows promising results using neurotechnological approaches to treat youth depression

New research shows promising results using neurotechnological approaches to treat depression in youth. The research, led by Simon Fraser University (SFU) professor Faranak Farzan, is published in the Journal of Affective Disorders Reports.

1 Dec 2022

Discontinuation of opioid therapy for pain may increase overdose risk

Opioid-related overdose is now a leading cause of accidental death in the United States and Canada. A study published December 1st in the open access journal PLOS Medicine by Mary Clare Kennedy at University of British Columbia, Kelowna, Canada, and colleagues suggests discontinuing prescribed opioids was associated with increased overdose risk.

1 Dec 2022

New evidence on the links between immune activation and neuroinflammation and Parkinson's disease

In this special supplement to the Journal of Parkinson's Disease, "The Immune System in Parkinson's Disease," experts highlight the latest research breakthroughs on the links between immune activation and neuroinflammation and Parkinson's disease (PD) and discuss the challenges and novel therapeutic strategies targeting the immune system with the hope of reducing or reversing neurodegeneration.

1 Dec 2022

Medical News

Primary and original booster mRNA vaccination can reduce the risk of Omicron-related infection

New program lowers the risk of car crashes for teenagers with ADHD

Best practices and challenges in One Health approach to fight zoonotic diseases

Self-driven healthcare ecosystems could help improve health outcomes and control costs

LSHTM researchers launch new global health research group on HIV-associated fungal infections

Study implicates gut microbiome health in Parkinson's disease

First-in-humans test provides promising results for a broadly neutralizing antibody HIV vaccine

Gargling with povidone-iodine may reduce salivary viral load in COVID-19 patients

Researchers develop a self-powered ingestible sensor system to monitor intestinal metabolites

Very low-calorie and vegan diets improve glycemic control in type 2 diabetes

Human T cell immunity is coping with mutations in SARS-CoV-2 variants of concern

Prior infection and vaccination protects against severe outcomes from SARS-CoV-2 Omicron infection

Using DECT-derived metrics to definitively diagnose incidental adrenal adenomas

COVID-19 infection may lead to long-term liver injury

Two experimental mRNA vaccines highly effective in reducing malaria infection and transmission

Harmful gut bacteria co-opt a genetic susceptibility to trigger Crohn’s disease

Study identifies optimal blood tests for Alzheimer's detection and disease monitoring

Research shows promising results using neurotechnological approaches to treat youth depression

Discontinuation of opioid therapy for pain may increase overdose risk

New evidence on the links between immune activation and neuroinflammation and Parkinson's disease

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News